Source link : https://www.newshealth.biz/health-news/omvoh-approved-for-crohns-fitbit-predicts-ibd-flares-h-pylori-and-gastric-cancer/
The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active Crohn’s disease, drugmaker Eli Lilly announced; the first-in-class interleukin-23 antagonist was previously approved for ulcerative colitis. In Crohn’s disease patients, adherence to a Mediterranean diet was associated with better clinical outcomes and decreases in markers of inflammation, […]
Author : News Health
Publish date : 2025-01-16 19:35:24
Copyright for syndicated content belongs to the linked Source.